Peptide Knowledge Base · Metabolic
AOD-9604: what it is, what the evidence says, and its real status
A fragment of growth hormone marketed for fat loss, with weak human evidence.
Short version: a GH-fragment pitched for fat loss whose human trials largely disappointed. Education only; we don't sell weak-evidence weight claims.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: Education only · Education only.
Not offered. AOD-9604 is a growth-hormone fragment marketed for fat loss; controlled human trials did not show meaningful weight benefit. We keep it education-only and make no weight-loss claims.
How does AOD-9604 work?
A synthetic fragment of the C-terminus of human growth hormone, proposed to influence fat metabolism without GH's systemic effects.
What it does — and what it does not do
What it does: Studied for fat metabolism.
What it does not do: It did not show meaningful weight loss in controlled human trials, and it is not offered here.
How honest is the evidence?
Evidence grade D — controlled human fat-loss trials largely negative. Read our grading methodology for what each grade means.
What we still don't know: No credible evidence of clinically meaningful fat loss in humans.
WADA status: Not prohibited.
How it is taken
Not offered; education only.
Who should not take it
Not characterized for any therapeutic use; not a weight-loss treatment.
Sources
AOD-9604 clinical trial literature (predominantly negative for weight loss)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.